Vimarsana
Biggest News Aggregation in the World

Page 28 - Every June News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Every June. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Every June Today - Breaking & Trending Today

Pride Month mythologizes transgender women of color like Sylvia Rivera, but that erases true history - Vimarsana News

Pride Month mythologizes transgender women of color like Sylvia Rivera, but that erases true history

Every June, we’re told a similar story — and it actively works against the most marginalized LGBTQ group.

BÄRNKOPF - Maibaum-Diebe wurden auch Opfer - Vimarsana News

BÄRNKOPF - Maibaum-Diebe wurden auch Opfer

Während die Diebe den Maibaum nach Bärnkopf brachten, stahl man ihnen Bäume.

Source: noen.at
European Hematology Association - Pegcetacoplan Maintains a Durable Response in Patients with Paroxysmal Nocturnal Hemoglobinuria Through Week 48 - Vimarsana News

European Hematology Association - Pegcetacoplan Maintains a Durable Response in Patients with Paroxysmal Nocturnal Hemoglobinuria Through Week 48

- THE HAGUE, Netherlands, June 12, 2021 /PRNewswire/ -- The PEGASUS phase-3 study previously demonstrated that pegcetacoplan, a drug controlling intra...

Source: iltempo.it
European Hematology Association - Pegcetacoplan Maintains a Durable Response in Patients with Paroxysmal Nocturnal Hemoglobinuria Through Week 48 - Vimarsana News

European Hematology Association - Pegcetacoplan Maintains a Durable Response in Patients with Paroxysmal Nocturnal Hemoglobinuria Through Week 48

/PRNewswire/ -- The PEGASUS phase-3 study previously demonstrated that pegcetacoplan, a drug controlling intra- and extravascular hemolysis, was superior to...

European Hematology Association - Daratumumab Maintenance Improves Progression-Free Survival After Autologous Stem Cell Transplantation in Multiple Myeloma Patients - Vimarsana News

European Hematology Association - Daratumumab Maintenance Improves Progression-Free Survival After Autologous Stem Cell Transplantation in Multiple Myeloma Patients

/PRNewswire/ -- Part 1 of the CASSIOPEIA phase-3 study compared the addition of daratumumab to bortezomib, thalidomide, and dexamethasone (D-VTd)...